ATE303396T1 - Verfahren zur herstellung von n6-substituierten aminopurin ribofuranose nucleosiden - Google Patents

Verfahren zur herstellung von n6-substituierten aminopurin ribofuranose nucleosiden

Info

Publication number
ATE303396T1
ATE303396T1 AT02718299T AT02718299T ATE303396T1 AT E303396 T1 ATE303396 T1 AT E303396T1 AT 02718299 T AT02718299 T AT 02718299T AT 02718299 T AT02718299 T AT 02718299T AT E303396 T1 ATE303396 T1 AT E303396T1
Authority
AT
Austria
Prior art keywords
producing
nucleosides
substituted aminopurine
substituted
compounds
Prior art date
Application number
AT02718299T
Other languages
English (en)
Inventor
Malcolm Berry
John C Roberts
Shiping Xie
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE303396T1 publication Critical patent/ATE303396T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
AT02718299T 2001-03-20 2002-03-19 Verfahren zur herstellung von n6-substituierten aminopurin ribofuranose nucleosiden ATE303396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0106867.5A GB0106867D0 (en) 2001-03-20 2001-03-20 Process
PCT/GB2002/001344 WO2002074781A1 (en) 2001-03-20 2002-03-19 Process for preparing n6-substituted aminopurine ribofuranose nucleosides

Publications (1)

Publication Number Publication Date
ATE303396T1 true ATE303396T1 (de) 2005-09-15

Family

ID=9911093

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02718299T ATE303396T1 (de) 2001-03-20 2002-03-19 Verfahren zur herstellung von n6-substituierten aminopurin ribofuranose nucleosiden

Country Status (8)

Country Link
US (1) US7297787B2 (de)
EP (1) EP1370569B1 (de)
JP (1) JP2004534003A (de)
AT (1) ATE303396T1 (de)
DE (1) DE60205875T2 (de)
ES (1) ES2243707T3 (de)
GB (1) GB0106867D0 (de)
WO (1) WO2002074781A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0115178D0 (en) * 2001-06-20 2001-08-15 Glaxo Group Ltd Compounds
US20050222178A1 (en) * 2002-06-17 2005-10-06 Mark Shipton Process
WO2004055032A1 (en) * 2002-12-18 2004-07-01 Glaxo Group Limited Adenosine derivative in polymorph v form
WO2004055033A1 (en) * 2002-12-18 2004-07-01 Glaxo Group Limited Adenosine derivative in polymorph iv form

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
GB9610031D0 (en) 1996-05-14 1996-07-17 Glaxo Group Ltd Chemical compounds
AU3255097A (en) 1996-07-05 1998-02-02 Novo Nordisk A/S Novel (n)-alkoxyadenine derivatives acting as cytokine inhibitors
UA51716C2 (uk) * 1996-07-08 2002-12-16 Авентіс Фармасьютікалз Продактс Інк. Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування
AU4377397A (en) 1996-10-14 1998-05-11 Novo Nordisk A/S Novel therapeutically active adenosine derivatives
GB9723566D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9723589D0 (en) 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9723590D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
CZ9901996A3 (cs) * 1999-06-04 2001-01-17 Ústav organické chemie a biochemie AV ČR Nové 6-fenylpurinové 9-ß-D-ribonukleosidy s antineoplastickým účinkem, jejich použití k přípravě farmaceutických preparátů a farmaceutické přípravky, které je obsahují

Also Published As

Publication number Publication date
US7297787B2 (en) 2007-11-20
JP2004534003A (ja) 2004-11-11
WO2002074781A1 (en) 2002-09-26
GB0106867D0 (en) 2001-05-09
EP1370569A1 (de) 2003-12-17
EP1370569B1 (de) 2005-08-31
US20050176949A1 (en) 2005-08-11
DE60205875T2 (de) 2006-05-04
DE60205875D1 (de) 2005-10-06
ES2243707T3 (es) 2005-12-01

Similar Documents

Publication Publication Date Title
MX2010013678A (es) Nucleotidos y nucleosidos y metodos para su uso en secuenciacion de adn.
TR200001340A2 (tr) Nükleosit analogların sentezi için proses
ATE521718T1 (de) Prozess zur synthetisierung von nukleinsäure
ES2076146T3 (es) Derivados de desaza-purina-nucleosidos, procedimiento para su preparacion asi como su utilizacion en el secuenciamiento de acidos nucleicos y en calidad de agentes antiviricos.
WO2005059157A3 (en) METHODS AND COMPOSITIONS FOR USE IN PREPARING HAIRPIN RNAs
Caton-Williams et al. Convenient synthesis of nucleoside 5′-triphosphates for RNA transcription
DE60214864D1 (de) Verfahren zur herstellung von nukleinsäuren bestehend aus stochastisch kombinierten anteilen von ausgangsnukleinsäuren
ATE303396T1 (de) Verfahren zur herstellung von n6-substituierten aminopurin ribofuranose nucleosiden
Matyašovský et al. 2-Substituted 2′-deoxyinosine 5′-triphosphates as substrates for polymerase synthesis of minor-groove-modified DNA and effects on restriction endonuclease cleavage
MXPA06000162A (es) Sintesis de ?-l-2-desoxinucleosidos.
WO2000061594A3 (de) Nucleosid-derivate mit photolabilen schutzgruppen
ATE332910T1 (de) Verfahren zur herstellung von 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofura osyl)-9h-purin-6-amin
BRPI0514718A (pt) método para a preparação de 2'-desoxi-2', 2'-diflúor-citidina
DE60204859D1 (de) Verfahren zur herstellung von 2'-fluoro-beta-l-arabinofuranosylnukleosiden
Koshkin Syntheses and base-pairing properties of locked nucleic acid nucleotides containing hypoxanthine, 2, 6-diaminopurine, and 2-aminopurine nucleobases
MX2007002156A (es) Metodo para la preparacion de 2' -dioxi -2' , 2' -difluoro-citidina.
Wolf et al. Synthesis of guanosine 5′-conjugates and their use as initiator molecules for transcription priming
DE602006009282D1 (de) Verfahren zur Herstellung von Cladribin
Siddiqui et al. A new synthetic approach to the clinically useful, anti-HIV-active nucleoside, 9-(2, 3-dideoxy-2-fluoro-β-D-threo-pentofuranosyl) adenine (β-FddA). Introduction of a 2′-β-fluoro substituent via inversion of a readily obtainable 2′-α-fluoro isomer
ATE231492T1 (de) Verfahren zur herstellung von pyrrolamiden
ATE241619T1 (de) Verfahren zur herstellung von nukleosid-analogen
ATE548366T1 (de) Verfahren zur herstellung von dioxolan nukleosidanalogavorstufen
DE60021875D1 (de) Verfahren zur herstellung von nukleosid-verbindung
Matsuda et al. Conversion of guanosine into 2-aminomethylinosine (2-homoguanosine)
JP2006131596A (ja) ヌクレオチド及びその誘導体の製造方法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties